Lancet Diabetes and Endocrinology
Journal Abbreviation: Lancet Diabetes Endocrinol
ISSN: 2213-8587
eISSN: 2213-8595
Publisher: Elsevier: Lancet
Publications (5)
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials (2025)
Badve SV, Bilal A, Lee MM, Sattar N, Gerstein HC, Ruff CT, McMurray JJ, et al.
Journal article
Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study (2023)
Medas F, Dobrinja C, Al-Suhaimi EA, Altmeier J, Anajar S, Arikan AE, Azaryan I, et al.
Journal article
Consensus on diagnosis and management of Cushing's disease: a guideline update (2021)
Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, et al.
Journal article, Review article
BPA and risk assessment. (2020)
Calafat AM, Koch HM, Andra SS, Antignac JP, Castaño A, Choi K, Covaci A, et al.
Journal article, Letter
Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials (2020)
Mann J, Hansen T, Idorn T, Leiter LA, Marso SP, Rossing P, Seufert J, et al.
Journal article
